2-Fluoro-4-methoxybenzonitrile | CAS:94610-82-9

We serve 2-Fluoro-4-methoxybenzonitrile CAS:94610-82-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Fluoro-4-methoxybenzonitrile

Chemical Name:   2-Fluoro-4-methoxybenzonitrile
CAS.NO: 94610-82-9
Synonyms:benzonitrile,2-fluoro-4-methoxy;
2-Fluoro-4-methoxy-benzonitrile;
fluoro-4-methoxy-benzonitrile;
4-Cyano-3-fluoroanisole;
3-FLUORO-4-CYANO ANISOLE;
Molecular Formula:C8H6FNO
Molecular Weight: 151.13800
 
Physical and Chemical Properties:
Density: 1.18g/cm3
Melting point: /
Boiling point: 233.9ºC at 760mmHg
Flash point:95.3ºC
Index of Refraction:1.505
 
Specification:
Appearance: white solid
Purity:≥99.0%
 
Packing:25kg/drum
Storage:Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application:   used in thePharmaceutical intermediate



Contact us for information like 2-Fluoro-4-methoxybenzonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-FLUORO-4-CYANO ANISOLE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,fluoro-4-methoxy-benzonitrile Use and application,2-Fluoro-4-methoxy-benzonitrile technical grade,usp/ep/jp grade.


Related News: Secretary of Health Francisco Duque said authorities are working with the Chinese embassy to respectfully handle the remains of the man while following international protocol to contain the disease.3-Aminophthalic acid manufacturer Domestic API companies cooperate with major international companies through commissioned processing, patent transfer, and joint venture production.Thiosemicarbazide supplier Domestic API companies cooperate with major international companies through commissioned processing, patent transfer, and joint venture production.trans-4-Methylcyclohexylamine hydrochloride vendor The program will run alongside our ongoing Phase 3 INSPIRE Trial, and is expected to continue until commercial launch in such countries.That notice came two days after Chinese President Xi Jinping — a well known TCM advocate — called for the “combination of Chinese and Western medicine” in the diagnosis and treatment of the disease at a meeting of the Communist Party’s Politburo Standing Committee, the country’s supreme ruling body.